Kodiak Sciences Inc (KOD : NASDAQ)
Common Stock
$89.60
USD
+1.97 (2.25%)
Last updated: 2026-10-26
Follow KOD
KOD
Kodiak Sciences Inc
WealthAwesomePerformance
1 Day
+2.25%
1 Week
-1.92%
1 Month
+176.97%
YTD
+150.91%
Key Statistics
Market Cap
$5.63B
52W High
$104.00
52W Low
$15.83
P/E Ratio
-
50 Day MA
$59.19
200 Day MA
$40.72
Beta
2.04
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/26/2026 | $88.03 | $91.89 | $87.61 | $89.60 | $89.60 | 926,846 |
| 10/23/2026 | $85.13 | $87.85 | $83.16 | $87.63 | $87.63 | 526,900 |
| 10/22/2026 | $87.14 | $89.52 | $84.86 | $85.78 | $85.78 | 593,406 |
| 10/21/2026 | $91.14 | $94.64 | $87.29 | $87.72 | $87.72 | 943,268 |
| 10/20/2026 | $90.84 | $96.12 | $89.53 | $92.97 | $92.97 | 857,755 |
| 10/19/2026 | $86.84 | $92.74 | $86.50 | $91.35 | $91.35 | 1,047,299 |
| 10/16/2026 | $87.18 | $89.78 | $85.20 | $85.75 | $85.75 | 1,122,100 |
| 10/15/2026 | $81.30 | $88.50 | $79.06 | $88.12 | $88.12 | 1,394,400 |
| 10/14/2026 | $90.62 | $90.62 | $80.14 | $81.09 | $81.09 | 2,403,929 |
| 10/13/2026 | $99.29 | $99.55 | $91.27 | $91.63 | $91.63 | 1,534,199 |
Analyst Price Targets
Based on 7 analysts covering KOD · as of Oct 14, 2026
Wall Street analysts forecast KOD stock price to rise 35.8% over the next 12 months.
Consensus
Strong Buy4.57 / 5.00
Avg. Target
US$121.67
+35.8% Upside
Previously US$116.67 on Oct 5, 2026
Current Price
US$89.60
Last close
Analyst Breakdown (7 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KOD's historical volatility
30-Day Vol
305.0%
Annualized
90-Day Vol
182.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$107.12
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$95.10 | US$33.20 – US$272.38 |
| 60 trading days | US$100.93 | US$22.79 – US$447.02 |
| 90 trading days | US$107.12 | US$17.31 – US$662.88 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Kodiak Sciences Inc
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-230.98M
- Profit Margin
- 0.00%
- ROE (TTM)
- -368.37%
- EPS (Diluted)
- -4.19
- Book Value
- 0.97
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About KOD.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GCTK | GlucoTrack Inc | $1.61 | +99.75% |
| NVNIF | Nvni Group Limited | $0.13 | +78.57% |
| AFJKR | Aimei Health Technology Co., Ltd Right | $0.14 | +63.54% |
| CLRO | ClearOne Inc | $4.97 | +52.92% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.04 | +48.00% |
| SGRY | Surgery Partners Inc | $23.25 | +47.62% |
| FEED | ENvue Medical Inc. | $0.25 | +37.42% |
| RFAI | RF Acquisition Corp II Ordinary Shares | $35.83 | +37.02% |
KOD.US news timeline
2 articles covering KOD.US, most recent first
Latest